Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
The Annals of Pharmacotherapy
|
May 10, 2013
Pharmacist-physician collaboration for diabetes care: the diabetes initiative program
Michelle Zingone Farland, Debbie C Byrd, M Shawn McFarland, et al.
The Journal of Infectious Diseases
|
October 20, 2005
Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay
Roxana E Rojas, Keith A Chervenak, Jeremy Thomas, et al.
Breast (Edinburgh, Scotland)
|
April 10, 2016
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project
Anthony J Maxwell, Karen Clements, David J Dodwell, et al.
Journal of Clinical Pathology
|
February 15, 2018
Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology
Benjamin F Dessauvagie, Andrew H S Lee, Katie Meehan, et al.
Histopathology
|
May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH
John M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2009
Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
Nicola S Russell, Ian H Kunkler, Geertjan van Tienhoven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2006
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
Matthew J Ellis, Yu Tao, Oliver Young, et al.
British Journal of Cancer
|
March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes
Hervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
The Lancet. Oncology
|
January 19, 2010
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
John M S Bartlett, Alison F Munro, Janet A Dunn, et al.
The Journal of Pathology. Clinical Research
|
August 9, 2016
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
Andrew R Green, Daniele Soria, Jacqueline Stephen, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
The Annals of Pharmacotherapy
|
May 10, 2013
Pharmacist-physician collaboration for diabetes care: the diabetes initiative program
Michelle Zingone Farland, Debbie C Byrd, M Shawn McFarland, et al.
The Journal of Infectious Diseases
|
October 20, 2005
Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay
Roxana E Rojas, Keith A Chervenak, Jeremy Thomas, et al.
Breast (Edinburgh, Scotland)
|
April 10, 2016
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project
Anthony J Maxwell, Karen Clements, David J Dodwell, et al.
Journal of Clinical Pathology
|
February 15, 2018
Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology
Benjamin F Dessauvagie, Andrew H S Lee, Katie Meehan, et al.
Histopathology
|
May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH
John M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2009
Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
Nicola S Russell, Ian H Kunkler, Geertjan van Tienhoven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2006
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
Matthew J Ellis, Yu Tao, Oliver Young, et al.
British Journal of Cancer
|
March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes
Hervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
The Lancet. Oncology
|
January 19, 2010
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
John M S Bartlett, Alison F Munro, Janet A Dunn, et al.
The Journal of Pathology. Clinical Research
|
August 9, 2016
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
Andrew R Green, Daniele Soria, Jacqueline Stephen, et al.
Page
of 8